User fee negotiations in US offer hope for improvements to interactive review for medical device submissions
This article was originally published in SRA
Executive Summary
Kristin M Zielinski discusses the shortfalls of the Food and Drug Administration's interactive review programme and the improvements "on the table".
You may also be interested in...
User fee negotiations in US offer hope for improvements to interactive review for medical device submissions
Kristin M Zielinski discusses the shortfalls of the Food and Drug Administration's interactive review programme and the improvements "on the table".